603977.SH
国泰集团
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 11.76
+0.94%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.4B | 2.4B | 2.4B | 2.5B | 2.2B |
| Cost of Revenue | 1.5B | 1.5B | 1.5B | 1.6B | 1.4B |
| Gross Profit | 854.3M | 856.5M | 862.8M | 912.9M | 761.4M |
| Operating Expenses | |||||
| R&D Expense | 140.0M | 132.8M | 131.2M | 138.1M | 116.8M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 296.8M | 291.4M | 283.3M | 265.3M | 227.2M |
| Selling & Marketing Expense | 93.4M | 91.6M | 98.2M | 101.2M | 80.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 555.9M | 542.0M | 531.6M | 516.6M | 452.5M |
| Cost and Expenses | 2.1B | 2.0B | 2.0B | 2.1B | 1.8B |
| Operating Income (EBIT) | 304.7M | 310.2M | 269.1M | 406.4M | 214.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 298.5M | 304.4M | 267.4M | 403.6M | 214.9M |
| Income Tax Expense | 34.3M | 36.9M | 47.6M | 50.9M | 35.1M |
| Bottom Line | |||||
| Net Income | 249.1M | 252.2M | 180.7M | 305.5M | 143.7M |
| Earnings from Cont. Ops | 264.2M | 267.5M | 219.8M | 352.7M | 179.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 249.1M | 252.2M | 180.7M | 305.5M | 143.7M |
| Per Share | |||||
| Basic EPS | CN¥0.40 | CN¥0.41 | CN¥0.29 | CN¥0.49 | CN¥0.24 |
| Diluted EPS | CN¥0.40 | CN¥0.41 | CN¥0.29 | CN¥0.49 | CN¥0.24 |
| Revenue Per Share | CN¥3.57 | CN¥3.84 | CN¥3.78 | CN¥4.08 | CN¥3.60 |
| Shares | |||||
| Basic Shares Outstanding | 665.5M | 615.2M | 623.3M | 623.6M | 598.7M |
| Diluted Shares Outstanding | 665.5M | 615.2M | 623.3M | 623.6M | 598.7M |
| Profitability Metrics | |||||
| EBITDA | — | 457.7M | 379.8M | 498.6M | 298.1M |
| D&A | — | 147.5M | 110.6M | 92.3M | 83.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026